Targeting cardiac hypertrophy: toward a causal heart failure therapy

E Bisping, P Wakula, M Poteser… - Journal of …, 2014 - journals.lww.com
Cardiac hypertrophy is commonly observed in conditions of increased hemodynamic or
metabolic stress. This hypertrophy is not compensatory but rather reflects activation of …

Beta blockers, nitric oxide, and cardiovascular disease

PM Vanhoutte, Y Gao - Current opinion in pharmacology, 2013 - Elsevier
The third generation β-blockers possess important ancillary properties besides inhibiting β-
adrenoceptors. Among them, nebivolol activates nitric oxide synthase (NOS). Nebivolol and …

Myocardial bridges: Overview of diagnosis and management

IS Rogers, JA Tremmel… - Congenital Heart Disease, 2017 - Wiley Online Library
A myocardial bridge is a segment of a coronary artery that travels into the myocardium
instead of the normal epicardial course. Although it is general perception that myocardial …

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

TD Giles, MA Weber, J Basile, AH Gradman… - The Lancet, 2014 - thelancet.com
Background The fixed-dose combination of any two antihypertensive drugs from different
drug classes is typically more effective in reducing blood pressure than a dose increase of …

[HTML][HTML] Left anterior descending myocardial bridge: angiographic prevalence and its association to atherosclerosis

A Matta, R Canitrot, V Nader, S Blanco… - Indian heart …, 2021 - Elsevier
Abstract Objective Left anterior descending Myocardial Bridge (LADMB) is considered a
benign condition and actually becomes a forgotten cause of serious cardiac events. This …

Erectile dysfunction and adherence to antihypertensive therapy: focus on β-blockers

A Manolis, M Doumas, C Ferri, G Mancia - European Journal of Internal …, 2020 - Elsevier
The management of arterial hypertension is very challenging in everyday clinical practice.
Blood pressure control rates remain disappointingly low, despite intense efforts. Poor …

Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide–sensitive human hypertension

LE Okamoto, A Gamboa, CA Shibao, AC Arnold… - …, 2014 - Am Heart Assoc
Nebivolol, unlike other selective β1-receptor blockers, induces vasodilation attributable to
increased NO bioavailability. The relative contribution of this mechanism to the blood …

The pharmacology of autonomic failure: from hypotension to hypertension

I Biaggioni - Pharmacological reviews, 2017 - ASPET
Primary neurodegenerative autonomic disorders are characterized clinically by loss of
autonomic regulation of blood pressure. The clinical picture is dominated by orthostatic …

Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation

MG Feng, MC Prieto, LG Navar - American Journal of …, 2012 - journals.physiology.org
Nebivolol is a β1-adrenergic blocker that also elicits renal vasodilation and increases the
glomerular filtration rate (GFR). However, its direct actions on the renal microvasculature …

Modulation of reactive oxygen species homeostasis as a pleiotropic effect of commonly used drugs

C Thomas, L Wurzer, E Malle, M Ristow… - Frontiers in …, 2022 - frontiersin.org
Age-associated diseases represent a growing burden for global health systems in our aging
society. Consequently, we urgently need innovative strategies to counteract these …